Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.06 +0.04 (+2.23%)
As of: Oct 21, 2026 · 2:33 PM EDT

Acumen Pharmaceuticals (ABOS) Non-Current Assets (2021 - 2026)

Updated

Acumen Pharmaceuticals (ABOS) reported Non-Current Assets of $494,000 for Q2 2026, down 97.9% from $23.49 million a year earlier and down 7.7% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Non-Current Assets (2021 - 2026) Analysis & Trends

At the end of FY2025, Acumen Pharmaceuticals posted Non-Current Assets of $581,000, down 99.0% from FY2024.

  • Non-Current Assets has a four-year compound annual growth rate of -63.2% (FY2021 to FY2025).
  • By year, Non-Current Assets came in at $60.69 million in FY2024 (-4.4%), $63.51 million in FY2023 (+290.6%), $16.26 million in FY2022 (-48.7%) and $31.67 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets in data going back to Q2 2021.
  • Year over year, Non-Current Assets has now declined in each of the last four quarters, with an average decline of 47.4% over the last eight quarters.
  • The high point for year-over-year Non-Current Assets in five years was Q2 2022 (growth of 769.9%); the low point was Q4 2025 (a decline of 99.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $535,000 (Q1 2026), $581,000 (Q4 2025) and $10.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,135.99 Bn 1,104.58 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 616.90 Bn 535.42 Bn 17.26 Bn 141.29 Bn
3 AbbVie 501.56 Bn 474.68 Bn 12.70 Bn 101.45 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.45 Bn 235.13 Bn 12.86 Bn 87.87 Bn
7 Amgen 236.48 Bn 191.88 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 190.56 Bn 164.76 Bn 6.22 Bn 35.42 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 159.77 Bn
10 Acumen Pharmaceuticals 148.11 Mn -333.96 Mn - 494,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 494,000.00
Mar 31, 2026 535,000.00
Dec 31, 2025 581,000.00
Sep 30, 2025 10.07 Mn
Jun 30, 2025 23.49 Mn
Mar 31, 2025 49.53 Mn
Dec 31, 2024 60.69 Mn
Sep 30, 2024 59.34 Mn
Jun 30, 2024 22.00 Mn
Mar 31, 2024 45.14 Mn
Dec 31, 2023 63.51 Mn
Sep 30, 2023 67.77 Mn
Jun 30, 2023 27.87 Mn
Mar 31, 2023 43.83 Mn
Dec 31, 2022 16.26 Mn
Sep 30, 2022 704,000.00
Jun 30, 2022 20.63 Mn
Mar 31, 2022 27.99 Mn
Dec 31, 2021 31.67 Mn
Sep 30, 2021 29.94 Mn
API Access

Acumen Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ABOS&period=max&api_key=YOUR_API_KEY